Women's Health Cluster Drug Development Pipeline Review, 2017

  • ID: 4258950
  • Report
  • Region: Global
  • 123 Pages
  • GBI Research
1 of 5

FEATURED COMPANIES

  • 4P Therapeutics LLC
  • Bayer AG
  • Evotec AG
  • Luye Pharma Group Ltd
  • Nora Therapeutics Inc
  • PharmaEssentia Corp
  • MORE

Women's Health Cluster Drug Development Pipeline Review, 2017

Summary

This report provides an overview of the women’s health pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for female infertility, polycystic ovarian syndrome and endometriosis, and also features dormant and discontinued projects.

Infertility is defined as the inability to get pregnant after a year of unprotected intercourse. Female infertility can be also be caused by a number of factors, which include damage to fallopian tubes, hormonal causes, cervical causes, uterine causes, unexplained infertility. There are a total of 87 products in development for this indication, by 47 companies and 11 academic institutions. Key companies operating in this pipeline space include Bayer, Evotec, AlphaMab, Zydus Cadila Healthcare and Ferring.

Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms include menstrual abnormality, acne, thinning hair on the scalp, weight gain, excess androgen and polycystic ovaries. There are a total of 12 products in development for this indication, by eight companies and three academic institutions. A number of companies are operating in this space, with EffRx alone developing multiple programs within the area.

Finally, endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (the endometrium) grows outside the uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. There are a total of 53 products in development for this indication, by 29 companies and eight academic institutions. Key companies operating in this pipeline space include Bayer and Evotec, which are each developing five distinct programs in this disease area.

Generally the main types of therapy being developed act on hormone receptors, reflecting the hormone-driven pathophysiology of this disease area. However, particularly in polycystic ovarian syndrome, a broader range of molecular targets, such as intracellular protein kinases, chemokine receptors and other cell signaling components are also targeted.

Scope

  • Which companies are the most active within the pipeline for women’s health therapeutics?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in the field of women’s health therapeutics?

Reasons to buy

  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 4P Therapeutics LLC
  • Bayer AG
  • Evotec AG
  • Luye Pharma Group Ltd
  • Nora Therapeutics Inc
  • PharmaEssentia Corp
  • MORE

1. Report Guidance

2. Executive Summary

3. Introduction

4. Women's Health Cluster Report Coverage

  • Women Infertility - Overview
  • Polycystic Ovarian Syndrome - Overview
  • Endometriosis - Overview

5. Therapeutics Development

  • Women Infertility
  • Polycystic Ovarian Syndrome
  • Endometriosis

6. Therapeutics Assessment

  • Women Infertility
  • Polycystic Ovarian Syndrome
  • Endometriosis

7. Companies Involved in Therapeutics Development

  • Women Infertility
  • Polycystic Ovarian Syndrome
  • Endometriosis
  • Dormant Projects
  • Women Infertility
  • Polycystic Ovarian Syndrome
  • Endometriosis

8. Discontinued Products

  • Women Infertility
  • Polycystic Ovarian Syndrome
  • Endometriosis

9. Product Development Milestones

  • Women Infertility
  • Polycystic Ovarian Syndrome
  • Endometriosis

10. Appendix

  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation

List of Tables

  • Number of Products under Development for Women Infertility
  • Number of Products under Development by Companies, Women Infertility
  • Number of Products under Development by Universities/Institutes, Women Infertility
  • Products under Development by Companies, Women Infertility
  • Products under Development by Universities/Institutes, Women Infertility
  • Number of Products under Development for Polycystic Ovarian Syndrome
  • Number of Products under Development by Companies, Polycystic Ovarian Syndrome
  • Number of Products under Development by Universities/Institutes, Polycystic Ovarian Syndrome
  • Products under Development by Companies, Polycystic Ovarian Syndrome
  • Products under Development by Universities/Institutes, Polycystic Ovarian Syndrome
  • Number of Products under Development for Endometriosis
  • Number of Products under Development by Companies, Endometriosis
  • Number of Products under Development by Universities/Institutes, Endometriosis
  • Products under Development by Companies, Endometriosis
  • Products under Development by Universities/Institutes, Endometriosis
  • Number of Products by Stage and Target, Women Infertility
  • Number of Products by Stage and Mechanism of Action, Women Infertility
  • Number of Products by Stage and Route of Administration, Women Infertility
  • Number of Products by Stage and Molecule Type, Women Infertility
  • Number of Products by Stage and Target, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Mechanism of Action, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Route of Administration, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Molecule Type, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Target, Endometriosis
  • Number of Products by Stage and Mechanism of Action, Endometriosis
  • Number of Products by Stage and Route of Administration, Endometriosis
  • Number of Products by Stage and Molecule Type, Endometriosis
  • Women Infertility - Pipeline by 4P Therapeutics LLC
  • Women Infertility - Pipeline by AbbVie Inc
  • Women Infertility - Pipeline by Addex Therapeutics Ltd
  • Women Infertility - Pipeline by AlphaMab Co Ltd
  • Women Infertility - Pipeline by APAvadis Biotechnologies Srl
  • Women Infertility - Pipeline by ASKA Pharmaceutical Co Ltd
  • Women Infertility - Pipeline by Astellas Pharma Inc
  • Women Infertility - Pipeline by Bayer AG
  • Women Infertility - Pipeline by Dong-A Socio Holdings Co Ltd
  • Women Infertility - Pipeline by Dongkook Pharmaceutical Co Ltd
  • Women Infertility - Pipeline by ElexoPharm GmbH
  • Women Infertility - Pipeline by EndoCeutics Inc
  • Women Infertility - Pipeline by Enteris BioPharma Inc
  • Women Infertility - Pipeline by Evotec AG
  • Women Infertility - Pipeline by Ferring International Center SA
  • Women Infertility - Pipeline by Forendo Pharma Ltd
  • Women Infertility - Pipeline by Glycotope GmbH
  • Women Infertility - Pipeline by Isifer AB
  • Women Infertility - Pipeline by Kissei Pharmaceutical Co Ltd
  • Women Infertility - Pipeline by Lipicard Technologies Ltd
  • Women Infertility - Pipeline by Livzon Pharmaceutical Group Inc
  • Women Infertility - Pipeline by Luye Pharma Group Ltd
  • Women Infertility - Pipeline by Merck & Co Inc
  • Women Infertility - Pipeline by Navya Biologicals Pvt Ltd
  • Women Infertility - Pipeline by Nippon Shinyaku Co Ltd
  • Women Infertility - Pipeline by Nora Therapeutics Inc
  • Women Infertility - Pipeline by ObsEva SA
  • Women Infertility - Pipeline by Ogeda SA
  • Women Infertility - Pipeline by Orphagen Pharmaceuticals Inc
  • Women Infertility - Pipeline by Pangen Biotech Inc.
  • Women Infertility - Pipeline by Pantec Biosolutions AG
  • Women Infertility - Pipeline by PharmaEssentia Corp
  • Women Infertility - Pipeline by Philogen SpA
  • Women Infertility - Pipeline by Repros Therapeutics Inc
  • Women Infertility - Pipeline by Richter Gedeon Nyrt
  • Women Infertility - Pipeline by SK Chemicals Co Ltd
  • Women Infertility - Pipeline by Takeda Pharmaceutical Company Ltd
  • Women Infertility - Pipeline by TocopheRx Inc
  • Women Infertility - Pipeline by ValiRx Plc
  • Women Infertility - Pipeline by Viramal Ltd
  • Women Infertility - Pipeline by Zydus Cadila Healthcare Ltd
  • Polycystic Ovarian Syndrome - Pipeline by Addex Therapeutics Ltd
  • Polycystic Ovarian Syndrome - Pipeline by Crinetics Pharmaceuticals Inc
  • Polycystic Ovarian Syndrome - Pipeline by EffRx Pharmaceuticals SA
  • Polycystic Ovarian Syndrome - Pipeline by Millendo Therapeutics Inc
  • Polycystic Ovarian Syndrome - Pipeline by Ogeda SA
  • Polycystic Ovarian Syndrome - Pipeline by Vicore Pharma AB
  • Endometriosis - Pipeline by AbbVie Inc
  • Endometriosis - Pipeline by Addex Therapeutics Ltd
  • Endometriosis - Pipeline by APAvadis Biotechnologies Srl
  • Endometriosis - Pipeline by Astellas Pharma Inc
  • Endometriosis - Pipeline by Bayer AG
  • Endometriosis - Pipeline by Dongkook Pharmaceutical Co Ltd
  • Endometriosis - Pipeline by ElexoPharm GmbH
  • Endometriosis - Pipeline by EndoCeutics Inc
  • Endometriosis - Pipeline by Enteris BioPharma Inc
  • Endometriosis - Pipeline by Evotec AG
  • Endometriosis - Pipeline by Forendo Pharma Ltd
  • Endometriosis - Pipeline by Kissei Pharmaceutical Co Ltd
  • Endometriosis - Pipeline by Lipicard Technologies Ltd
  • Endometriosis - Pipeline by Luye Pharma Group Ltd
  • Endometriosis - Pipeline by Nippon Shinyaku Co Ltd
  • Endometriosis - Pipeline by Ogeda SA
  • Endometriosis - Pipeline by Orphagen Pharmaceuticals Inc
  • Endometriosis - Pipeline by Philogen SpA
  • Endometriosis - Pipeline by Repros Therapeutics Inc
  • Endometriosis - Pipeline by SK Chemicals Co Ltd
  • Endometriosis - Pipeline by Takeda Pharmaceutical Company Ltd
  • Endometriosis - Pipeline by ValiRx Plc
  • Endometriosis - Pipeline by Viramal Ltd
  • Women Infertility - Dormant Projects
  • Polycystic Ovarian Syndrome - Dormant Projects
  • Endometriosis - Dormant Projects
  • Women Infertility - Discontinued Products
  • Polycystic Ovarian Syndrome - Discontinued Products
  • Endometriosis - Discontinued Products

List of Figures

  • Number of Products under Development for Women Infertility
  • Number of Products under Development by Companies, Women Infertility
  • Number of Products under Development by Universities/Institutes, Women Infertility
  • Number of Products under Development for Polycystic Ovarian Syndrome
  • Number of Products under Development by Companies, Polycystic Ovarian Syndrome
  • Number of Products under Development for Endometriosis
  • Number of Products under Development by Companies, Endometriosis
  • Number of Products under Development by Universities/Institutes, Endometriosis
  • Number of Products by Top 10 Targets, Women Infertility
  • Number of Products by Stage and Top 10 Targets, Women Infertility
  • Number of Products by Top 10 Mechanism of Actions, Women Infertility
  • Number of Products by Stage and Top 10 Mechanism of Actions, Women Infertility
  • Number of Products by Routes of Administration, Women Infertility
  • Number of Products by Stage and Routes of Administration, Women Infertility
  • Number of Products by Molecule Types, Women Infertility
  • Number of Products by Stage and Molecule Types, Women Infertility
  • Number of Products by Top 10 Targets, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Top 10 Targets, Polycystic Ovarian Syndrome
  • Number of Products by Top 10 Mechanism of Actions, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Top 10 Mechanism of Actions, Polycystic Ovarian Syndrome
  • Number of Products by Routes of Administration, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Routes of Administration, Polycystic Ovarian Syndrome
  • Number of Products by Molecule Types, Polycystic Ovarian Syndrome
  • Number of Products by Stage and Molecule Types, Polycystic Ovarian Syndrome
  • Number of Products by Top 10 Targets, Endometriosis
  • Number of Products by Stage and Top 10 Targets, Endometriosis
  • Number of Products by Top 10 Mechanism of Actions, Endometriosis
  • Number of Products by Stage and Top 10 Mechanism of Actions, Endometriosis
  • Number of Products by Routes of Administration, Endometriosis
  • Number of Products by Stage and Routes of Administration, Endometriosis
  • Number of Products by Molecule Types, Endometriosis
  • Number of Products by Stage and Molecule Types, Endometriosis
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 4P Therapeutics LLC
  • APAvadis Biotechnologies Srl
  • ASKA Pharmaceutical Co Ltd
  • AbbVie Inc
  • Addex Therapeutics Ltd
  • AlphaMab Co Ltd
  • Astellas Pharma Inc
  • Bayer AG
  • Crinetics Pharmaceuticals Inc
  • Dong-A Socio Holdings Co Ltd
  • Dongkook Pharmaceutical Co Ltd
  • EffRx Pharmaceuticals SA
  • ElexoPharm GmbH
  • EndoCeutics Inc
  • Enteris BioPharma Inc
  • Evotec AG
  • Ferring International Center SA
  • Forendo Pharma Ltd
  • Glycotope GmbH
  • Isifer AB
  • Kissei Pharmaceutical Co Ltd
  • Lipicard Technologies Ltd
  • Livzon Pharmaceutical Group Inc
  • Luye Pharma Group Ltd
  • Merck & Co Inc
  • Millendo Therapeutics Inc
  • Navya Biologicals Pvt Ltd
  • Nippon Shinyaku Co Ltd
  • Nora Therapeutics Inc
  • ObsEva SA
  • Ogeda SA
  • Orphagen Pharmaceuticals Inc
  • Pangen Biotech Inc.
  • Pantec Biosolutions AG
  • PharmaEssentia Corp
  • Philogen SpA
  • Repros Therapeutics Inc
  • Richter Gedeon Nyrt
  • SK Chemicals Co Ltd
  • Takeda Pharmaceutical Company Ltd
  • TocopheRx Inc
  • ValiRx Plc
  • Vicore Pharma AB
  • Viramal Ltd
  • Zydus Cadila Healthcare Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll